Pfizer
PFE
2,929 hedge funds and large institutions have $131B invested in Pfizer in 2023 Q3 according to their latest regulatory filings, with 126 funds opening new positions, 1,187 increasing their positions, 1,386 reducing their positions, and 207 closing their positions.
2% more funds holding in top 10
Funds holding in top 10: 51 → 52 (+1)
0.29% less ownership
Funds ownership: 69.54% → 69.25% (-0.29%)
8% less call options, than puts
Call options by funds: $2.44B | Put options by funds: $2.65B
4% less funds holding
Funds holding: 3,045 → 2,929 (-116)
10% less capital invested
Capital invested by funds: $145B → $131B (-$14.3B)
14% less repeat investments, than reductions
Existing positions increased: 1,187 | Existing positions reduced: 1,386
39% less first-time investments, than exits
New positions opened: 126 | Existing positions closed: 207
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$581M |
| 2 |
Charles Schwab
San Francisco,
California
|
+$332M |
| 3 |
Two Sigma Advisers
New York
|
+$287M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$251M |
| 5 |
D.E. Shaw & Co
New York
|
+$236M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$595M |
| 2 |
Capital International Investors
Los Angeles,
California
|
-$414M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$354M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$263M |
| 5 |
BlackRock
New York
|
-$220M |
PFE Hedge Fund Activity: Q3 2023 in Review
2,929 of the 6,311 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q3 2023, worth a combined $131B — down 9.8% from $145B a quarter earlier.
Sellers outnumbered buyers: 207 funds closed out of PFE and 126 opened new positions — a net loss of 81 holders — while 1,386 trimmed existing stakes and 1,187 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $581M. The largest seller was Capital World Investors, cutting an estimated $595M.
- 2,929 institutional investors held Pfizer (PFE) as of Q3 2023, down from 3,045 in Q2 2023.
- Funds reported $131B of Pfizer stock for Q3 2023, down 9.8% quarter-over-quarter.
- 126 funds opened new Pfizer positions in Q3 2023 and 207 closed out, a net change of -81 holders.
- The largest Pfizer buyer in Q3 2023 was T. Rowe Price Associates, an estimated $581M added.
- The largest Pfizer seller in Q3 2023 was Capital World Investors, an estimated $595M sold.
Based on aggregated 13F filings for Q3 2023.